TRIANA Biomedicines Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
TRIANA Biomedicines is a biotechnology research company focused on discovering and developing novel small molecules to treat disease. Its core approach relies on molecular glues—small molecules that promote the interaction between a target protein and a partner protein to alter the target's fate or function—opening therapeutic possibilities for targets long deemed undruggable. Based in Lexington, Massachusetts, the company operates its own laboratories and maintains collaborations with academic and industry partners. TRIANA pursues a target-first, rational discovery process for molecular glues, with an early emphasis on targeted protein degradation to advance cancer therapies. This positioning aligns the company with oncology-focused biopharma research as it seeks to broaden the range of tractable disease targets. As a mid-sized biotechnology enterprise, TRIANA engages in partnerships to advance its science and explore new applications.